[1]
De Marco, G. et al. 2007. Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy. Reumatismo. 59, 1 (Mar. 2007), 50–56. DOI:https://doi.org/10.4081/reumatismo.2007.50.